James Mullen - Biogen Idec
Total Compensation: $8.9 million
Details: Mullen garnered $1.14 million in base salary, $1.94 million in incentives and $159,625 in other compensation. Most of Mullen's earnings this year came from $7.23 million in stock. Despie the big numbers, Mullen earned almost a third less in 2007 than he did in 2006, primairly due to Biogen Idec's failed bid to find a buyer for the company.
Biogen Idec News:
Biogen squares off against Icahn [1]
Icahn aims for Biogen control [2]
Biogen CEO: Pharma too wimpy to deal [3]
Biogen shares deflate as it gives up on sale [3]
Biogen Idec in play after Icahn makes his move [4]
Links:
[1] http://www.fiercebiotech.com/story/biogen-squares-off-against-icahn-in-board-battle/2008-04-18
[2] http://www.fiercebiotech.com/story/icahn-aims-biogen-control/2008-01-29
[3] http://www.fiercebiotech.com/story/biogen-shares-deflate-it-gives-sale/2007-12-13
[4] http://www.fiercebiotech.com/story/biogen-idec-play-after-icahn-makes-his-move/2007-10-15
[5] http://www.fiercebiotech.com/special-reports/gilead-ceo-john-c-martin-ceo-pay-report
[6] http://www.fiercebiotech.com/special-reports/ceo-pay-who-makes-what-big-biotech